Oruka Therapeutics Inc [ORKA] stock prices are up 0.41% to $31.97 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ORKA shares have gain 6.21% over the last week, with a monthly amount glided 18.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Oruka Therapeutics Inc [NASDAQ: ORKA] stock has seen the most recent analyst activity on December 18, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $75. Previously, Jefferies started tracking the stock with Buy rating on November 13, 2025, and set its price target to $45. On October 27, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $60 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $48 on October 13, 2025. BTIG Research initiated its recommendation with a Buy and recommended $44 as its price target on May 22, 2025. Wolfe Research started tracking with a Outperform rating for this stock on February 04, 2025, and assigned it a price target of $20. In a note dated October 11, 2024, Stifel initiated an Buy rating and provided a target price of $49 on this stock.
The stock price of Oruka Therapeutics Inc [ORKA] has been fluctuating between $5.49 and $32.28 over the past year. Currently, Wall Street analysts expect the stock to reach $55.75 within the next 12 months. Oruka Therapeutics Inc [NASDAQ: ORKA] shares were valued at $31.97 at the most recent close of the market. An investor can expect a potential return of 74.38% based on the average ORKA price forecast.
Analyzing the ORKA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.28 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.47 points at the first support level, and at 28.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.04, and for the 2nd resistance point, it is at 34.12.
Ratios To Look Out For
It’s worth pointing out that Oruka Therapeutics Inc [NASDAQ:ORKA]’s Current Ratio is 16.94. Further, the Quick Ratio stands at 16.94, while the Cash Ratio is 4.35.
Transactions by insiders
Recent insider trading involved Goncalves Joana, Chief Medical Officer, that happened on Dec 19 ’25 when 7000.0 shares were sold. Officer, JOANA GONCALVES completed a deal on Dec 19 ’25 to buy 28000.0 shares. Meanwhile, 10% Owner Venrock Healthcare Capital Par bought 88794.0 shares on Feb 14 ’25.
